Eli Lilly
LLY
LLY
3,879 hedge funds and large institutions have $605B invested in Eli Lilly in 2024 Q4 according to their latest regulatory filings, with 498 funds opening new positions, 1,522 increasing their positions, 1,467 reducing their positions, and 195 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
9% less call options, than puts
Call options by funds: $9.28B | Put options by funds: $10.1B
12% less capital invested
Capital invested by funds: $686B → $605B (-$81.1B)
29% less funds holding in top 10
Funds holding in top 10: 468 → 330 (-138)
Holders
3,879
Holding in Top 10
330
Calls
$9.28B
Puts
$10.1B
Top Buyers
| 1 | +$1.55B | |
| 2 | +$1.27B | |
| 3 | +$1.15B | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$930M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$748M |
Top Sellers
| 1 | -$7.21B | |
| 2 | -$2.59B | |
| 3 | -$1.93B | |
| 4 |
Jennison Associates
New York
|
-$1.66B |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$1.25B |